AnaptysBio, Inc. ANAB Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| —— | —— | -$84.63M+36.2% | -$132.59M+5.7% | -$140.62M+3.2% | ||
| $543K-2.9% | $559K-2.4% | $573K-0.7% | $577K-2.0% | $589K-2.8% | ||
| $41.12M+14.0% | $36.07M+0.9% | $35.75M+2.8% | $34.78M+5.1% | $33.09M-2.8% | ||
| $4.48M-77.3% | $19.7M+114% | -$144.97M-13.5% | -$127.71M-17.4% | -$108.78M+19.6% | ||
| $69K-20.7% | $87K-75.1% | $349K-6.2% | $372K+1.6% | $366K+2.2% | ||
| $248.17M+8.8% | $228.03M— | —— | —— | —— | ||
| $64.2M-6.4% | $68.63M+4.5% | $65.7M+17.4% | $55.98M+1,047% | $4.88M+970% | ||
| -$102.81M+22.5% | -$132.61M-114% | -$61.91M-414% | $19.71M-82.4% | $112.1M-11.8% | ||
| $149.83M+30.2% | $115.12M— | —— | —— | —— | ||
| $4.41M-77.5% | $19.61M+113% | -$145.32M-13.5% | -$128.08M-17.3% | -$109.15M+19.6% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where does AnaptysBio, Inc.'s cash flow data come from?
- Every line is extracted from AnaptysBio, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.